Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May;39:101174.
doi: 10.1016/j.ctcp.2020.101174. Epub 2020 Apr 12.

Herbal Medicine for Treatment of Children Diagnosed With COVID-19: A Review of Guidelines

Affiliations
Free PMC article
Review

Herbal Medicine for Treatment of Children Diagnosed With COVID-19: A Review of Guidelines

Lin Ang et al. Complement Ther Clin Pract. .
Free PMC article

Abstract

This review aimed to summarize and analyze the pattern identification (PI), herbal formulae, and composition of herbs provided by recent guidelines for the treatment of pediatric COVID-19. Seven data sources were reviewed until March 25, 2020. We analyzed the herbal formulae included in the guidelines and performed a network analysis to identify the frequency of herbs recommended in the herbal formulae. All 3 guidelines were provincial guidelines from China. Our results showed that there were 4 stages, 12 PIs, and 13 herbal formulae recommended by the provincial guidelines. These herbal formulae included a total of 56 herbs. Based on our network analysis, Scutellariae Radix was paired with Artemisiae Annuae Herba in one cluster. In another cluster, Armeniacae Semen was paired with Coicis Semen and Ephedrae Herba was paired with Gypsum Fibrosum. This review serves as a reference for the use of traditional medicine in the treatment of pediatric COVID-19.

Keywords: COVID-19; Children; Herbal medicine; Pediatric; Traditional medicine.

Conflict of interest statement

Declaration of competing interest The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Network analysis of herbs with frequency of use of 3 or more times.

Similar articles

See all similar articles

References

    1. World Health Organization (WHO) WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
    1. Lai K.K.R., Wu J., Harris R., McCann A., Collins K., Watkins D., Patel J.K. Coronavirus map: tracking the spread of the outbreak. https://www.nytimes.com/interactive/2020/world/coronavirus-maps.html?action=click&module=RelatedLinks&pgtype=Article
    1. Lu X., Zhang L., Du H., Zhang J., Li Y.Y., Qu J., Zhang W., Wang Y., Bao S., Li Y., Wu C., Liu H., Liu D., Shao J., Peng X., Yang Y., Liu Z., Xiang Y., Zhang F., Silva R.M., Pinkerton K.E., Shen K., Xiao H., Xu S., Wong G.W.K. SARS-CoV-2 infection in children. N. Engl. J. Med. 2020 - PMC - PubMed
    1. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease Control and prevention. J. Am. Med. Assoc. 2020 - PubMed
    1. Luo H., Tang Q.L., Shang Y.X., Liang S.B., Yang M., Robinson N., Liu J.P. Can Chinese medicine Be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin. J. Integr. Med. 2020 - PMC - PubMed

Substances

Supplementary concepts

Feedback